Press release
What are the key drivers of significant growth of the Biosimilars Market? How the sales of the current market leader, Sandoz International, Pfizer, Biocon, Biogen Idec, Amgen, Celltrion, Roche, Samsung, will be affected by the launch of longer-acting anti
Geographically, Europe held the largest share, of 47.7%, in the biosimilars market in 2018. This is attributed to flexible regulatory framework, growing geriatric population, and rising R&D investment by biopharmaceutical companies in the region.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/biosimilars-market
The biosimilars market is anticipated to undergo fastest growth in North America, advancing at a CAGR of 32.7% during the forecast period. This can be mainly ascribed to rising geriatric population, increasing prevalence of chronic diseases, increase in R&D investments in the region.
According to the Population Reference Bureau report, “Aging in the United States”, the geriatric population is projected to reach more than double by 2060, which in turn, poses the requirement for management of old age-related diseases. Moreover, according to the Centers for Disease Control and Prevention (CDC), almost 60% of the U.S. adults have one or other chronic disease.
Moreover, companies in North America are more independent for pricing their products as compared to other regions, and trained scientific personnel and advanced technologies are readily accessible in North America, which make the region more suitable for pharmaceutical companies.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/biosimilars-market/report-sample
New product launches and strategic collaborations play an important role in expansion of the biosimilars market. For instance, Amgen Inc. and EnteraBio Ltd. announced a collaboration to develop orally-administered formulation of biologics in 2018. This shows that companies are willing to invest in biologics, which in turn, is expected to be a major driving factor for the growth of the market.
Furthermore, in January 2019, Samsung Bioepis Co. Ltd. partnered with 3SBio Group to expand the biosimilar business in China. Through the partnership, Samsung Bioepis Co. Ltd. will be able to widen its biosimilars portfolio and 3SBio Group will be benefited from the sales of Avastin.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=biosimilars-market
Some of the key players in the global biosimilars market are AMEGA Biotech, Samsung Bioepis Co. Ltd., Coherus BioSciences Inc., Synthon Holding B.V., BIOCAD, Zydus Cadila, Celltrion Inc., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Limited, Novartis AG, Pfizer Inc., and Mylan N.V.
Global Biosimilars Market Segmentation
Market Segmentation by Product
• Recombinant Glycosylated Proteins
o Monoclonal antibodies (mAbs)
o Erythropoietin
o Follitropin
• Recombinant Non-Glycosylated Proteins
o Insulin
o Recombinant human growth hormone
o Granulocyte-colony stimulating factor (G-CSF)
o Interferons
• Recombinant Peptides
Market Segmentation by Technology
• Monoclonal Antibody (mAb)
• Recombinant Deoxyribonucleic Acid (rDNA)
• Bioassays
• Nuclear Magnetic Resonance (NMR)
• Electrophoresis
Market Segmentation by Indication
• Oncology
• Rheumatology
• Blood-Related Disorders
• Auto-Immune Diseases
• Chronic Diseases
• Infectious Diseases
• Growth Hormone Deficiency (GHD)
• Others
Market Segmentation by Manufacturing Type
• Contract
• In-House
Market Segmentation by Route of Administration (ROA)
• Intravenous
• Subcutaneous
• Intranasal
• Others
Market Segmentation by Geography
• Europe Biosimilars Market
o By product
o By technology
o By indication
o By manufacturing type
o By ROA
o By country – Germany, France, U.K., Italy, Spain, Sweden, Russia, Switzerland, Austria, Netherlands, Belgium, Norway, and Rest of Europe
• Asia-Pacific (APAC) Biosimilars Market
o By product
o By technology
o By indication
o By manufacturing type
o By ROA
o By country – China, Japan, India, South Korea, Singapore, Australia, Thailand, Indonesia, Malaysia, and Rest of APAC
• North America Biosimilars Market
o By product
o By technology
o By indication
o By manufacturing type
o By ROA
o By country – U.S. and Canada
• Latin America (LATAM) Biosimilars Market
o By product
o By technology
o By indication
o By manufacturing type
o By ROA
o By country – Brazil, Mexico, Argentina,
Columbia, and Rest of LATAM
• Middle East & Africa (MEA) Biosimilars Market
o By product
o By technology
o By indication
o By manufacturing type
o By ROA
o By country – U.A.E., Israel, South Africa, Saudi Arabia, and Rest of MEA
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What are the key drivers of significant growth of the Biosimilars Market? How the sales of the current market leader, Sandoz International, Pfizer, Biocon, Biogen Idec, Amgen, Celltrion, Roche, Samsung, will be affected by the launch of longer-acting anti here
News-ID: 1794641 • Views: …
More Releases from P&S Intelligence
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media.
In order to pace up the 4th industrial revolution, businesses across various industries…
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Marke …
The total value of the customer engagement solutions market was $18,186.8 million in 2021, and it will rise at a growth rate of above 10% in the near future, to reach $43,398.9 million by 2030. The major reasons behind the growth of this industry are growing usage of such solutions in serval industries like healthcare, telecommunications, BFSI and FMCG.
North America will grow the fastest with a rate of 10.5% in…
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Marke …
The motion control market generated a revenue of $14,887.5 million in 2021, and it is expected to contribute $23,286.4 million in 2030, progressing at a rate of 5.1% from 2021 to 2030, ascribed to the rising demand for industrial robots and integration of components with the motion control systems for convenient use.
Moreover, the evolving motion control standards and protocols propel the market, for example, the OPC UA TSN protocol controls…
North America, the Largest Revenue Producer in Public Safety and Security Market
The size of the public safety and security market was at $411 billion in the year 2021, which will reach over $1,115 billion by the year 2030, advancing at a growth rate of around 12% in the years to come. This is largely ascribed to the rising application of innovative technologies in smart cities, increasing crime rates, the increasing cases of disastrous accidents, and the growing count of terrorist activities…
More Releases for Biosimilars
Global Biosimilars Market 2021-2028 | Price Advantage of Biosimilars Over Biolog …
The global Biosimilars market focuses on encompassing major statistical evidence for the Biosimilars industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition, the Biosimilars study also shifts its attention with an in-depth…
Growth of the Biosimilars Market Is Mainly Driven by Increasing Number of Approv …
A biosimilar is a biologic medical product that is similar to another already approved biological medicine, in terms of quality, safety, and efficacy. Biosimilars are a class of therapeutic drugs that provide additional treatment options and help reduce healthcare costs. Thus, there is an increasing demand for biosimilar drugs due to increasing prevalence of autoimmune diseases, key factor driving the growth of the biosimilars market. According to the National Stem…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Global Oral Biologics and Biosimilars Market | Global Oral Biologics and Biosimi …
The oral biologics and biosimilar market contain of sales of oral biologics and biosimilar products and associated services utilized to treat chronic syndromes such as diabetes, arthritis, cancer. Biologics are drugs completed from living cells using exceedingly complex technology while biosimilars are generated to function similarly to biologics but are not matching to biologics. Biosimilars offer energetic properties as any licensed biologic drug. The oral biologics and biosimilar market encompass…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…
